Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 2/20 | 0.46 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.40 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.40 |
| ▸ | ITGAL | P20701 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.37 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.36 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30406637 | 1.00 | ECE1 (0.46) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL88480 | 1.00 | ECE1 (0.46) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL28035646 | 0.88 | ECE1 (0.39) | ECE1ITGB2ICAM1ITGALCA2 | |
| Phenol SCHEMBL27348628 | 0.85 | ALDH1A1 (0.46) | ECE1ITGB2ICAM1ITGALCA2 | |
| Phenol SCHEMBL28342610 | 0.85 | ALDH1A1 (0.46) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL3856802 | 0.84 | ECE1 (0.42) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL7034111 | 0.84 | ECE1 (0.42) | ECE1ITGB2ICAM1ITGALCA2 | |
| Benzene SCHEMBL28092853 | 0.83 | ECE1 (0.39) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL1688082 | 0.83 | ECE1 (0.40) | ECE1ITGB2ICAM1ITGALCA2 | |
| SCHEMBL30089038 | 0.83 | ECE1 (0.44) | ECE1ITGB2ICAM1ITGALCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2085 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025199636-A1 | TARGETED RADIOLIGAND COMPOUNDS AND USES THEREOF | MCMASTER UNIVERSITY (CA) | 2025-10-02 | — | — | WO | claimed |
| US-20240383954-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | JANSSEN BIOTECH INC (US) | 2024-11-21 | — | — | US | claimed |
| US-11680088-B2 | Bioactive peptides derived from snakes | UNIVERSITEIT LEIDEN (NL) | 2023-06-20 | — | — | US | claimed |
| US-20230181518-A1 | PREVENTION OF ROSACEA INFLAMMATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-06-15 | — | — | US | claimed |
| EP-4090669-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | Janssen Biotech, Inc. (US) | 2022-11-23 | — | — | EP | claimed |
| CN-115297958-A | Microcapsules coated with polysuccinimide derivatives | 弗门尼舍有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-104045698-B | Polypeptide, polypeptide derivative, medicinal salt of polypeptide and medicinal composition | 深圳君圣泰生物技术有限公司 | 2019-04-16 | — | — | CN | claimed |
| EP-2341774-B1 | TREATMENT OF NEUROBLASTOMA WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN | BELROSE PHARMA INC (US) | 2013-12-04 | — | — | EP | claimed |
| US-20120322717-A9 | Compounds and assays for controlling Wnt activity | ENZO BIOCHEM, INC. | 2012-12-20 | — | — | US | claimed |
| US-20100298200-A1 | Compounds and assays for controlling Wnt activity | LIU DAKAI | 2010-11-25 | — | — | US | claimed |
| JP-2010524472-A | — | — | 2010-07-22 | — | — | JP | claimed |
| EP-2147116-A1 | STABLE RECOMBINANT ADENOSINE DEAMINASE | Enzon Pharmaceuticals, Inc. (US) | 2010-01-27 | — | — | EP | claimed |
| US-20090047271-A1 | STABLE RECOMBINANT ADENOSINE DEAMINASE | ENZON PHARMACEUTICALS, INC. (US) | 2009-02-19 | — | — | US | claimed |
| WO-2008131208-A1 | STABLE RECOMBINANT ADENOSINE DEAMINASE | ENZON PHARMACEUTICALS, INC. (US) | 2008-10-30 | — | — | WO | claimed |
| US-20260144848-A1 | METHOD FOR PREDICTING RESPONSE TO A CANCER TREATMENT | PEPTOMYC, S.L. (ES) | 2026-05-28 | — | — | US | disclosed |
| EP-3571216-B1 | APOC-II MIMETIC PEPTIDES | US HEALTH (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12637441-B2 | Prodrugs of the tyrosine kinase inhibitor for treating cancer | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2026-05-26 | — | — | US | disclosed |
| EP-0672057-A1 | ANALOGS OF PTH | Novartis AG (CH) | 1995-09-20 | — | — | EP | disclosed |
| CN-1099801-A | Peptides | SANDOZ LTD (CH) | 1995-03-08 | — | — | CN | disclosed |
| WO-1994002510-A2 | ANALOGS OF PTH | SANDOZ LTD. (CH) | 1994-02-03 | — | — | WO | disclosed |